Iovance Biotherapeutics, Inc. (IOVA) — SC 13G/A Filings
All SC 13G/A filings from Iovance Biotherapeutics, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Oct 18, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
MHR Fund Management Affirms Significant Stake in Iovance Biotherapeutics
— Feb 9, 2024 Risk: low
MHR Fund Management LLC, a New York-based investment firm, along with its affiliates and Dr. Mark H. Rachesky, filed an amended Schedule 13G/A on February 9, 20 -
BlackRock Maintains 6.0% Stake in Iovance Biotherapeutics
— Jan 26, 2024
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership in Iovance Biotherapeutics, Inc. as of December 31, 2023. This filing ind -
State Street Lowers Iovance Biotherapeutics Stake to 3.8%
— Jan 25, 2024
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of common stock in Iovance Biotherapeu
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX